Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells
In conclusion, a lipophilic bismuth nanoparticle hydrogel is an innovative, low-cost alternative for the topical treatment of cervicouterine, prostate, and colon human cancers.
Source: Anti-Cancer Drugs - Category: Cancer & Oncology Tags: Preclinical Reports Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | Cerebellum | Cervical Cancer | Colon Cancer | Colorectal Cancer | Docetaxel | Heart | Liver | Nanotechnology | Neurology | Study | Taxotere | Urology & Nephrology